Skip to content

Based on confirmation from the third part and objective performance criteria establishing the evidence-based pattern of individual diagnosis and treatment of traditional Chinese medicine

Based on confirmation from the third part and objective performance criteria establishing the evidence-based pattern of individual diagnosis and treatment of traditional Chinese medicine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015641
Enrollment
Unknown
Registered
2018-04-12
Start date
2018-04-16
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

Case series:individual diagnosis and treatment of traditional Chinese medicine

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients meeting diagnosis of IBS-D (Rome IV); (2) Patients providing signed informed consent; (3) Male or female aged 18 to 75 years; (4) Patients reporting a Irritable Bowel Syndromes Symptom Severity Score (IBS-SSS) of >75.

Exclusion criteria

Exclusion criteria: (1) Patients with alarm symptoms; (2) Patients with history or current evidence of inflammatory bowel disease; (3) Patients with history or current evidence of concurrent enteric infection, hyperthyroidism or other diseases causing diarrhea and abdominal pain; (4) Patients who report a anxiety score of > 50 on Self-rating Anxiety Scale (SAS) or a depression score of > 53 on Self-rating Depression Scale (SDS), or patients with other psychiatric disorders; (5) Patients with a history of gastrointestinal surgery causing similar syndromes with IBS; (6) Patients who are unable or unwilling to stop taking medication affecting the assessments of experimental drug efficacy and safety; (7) Patients who are pregnancy, breast feeding, or plan to conceive within 3 months; (8) Patients with concurrent serious diseases, such as cancer, serious cardiovascular, respiratory, hepatic, renal, or neurological disease; (9) Patients who are participating or have participated in another clinical trial within the previous 3 months; (10) Patients who are in researchers opinion unsuitable for this trial.

Design outcomes

Primary

MeasureTime frame
AR;

Secondary

MeasureTime frame
severity of abdominal pain;severity of abdominal discomfort;severity of abdominal distension;stool frequency;stool consistency;urgency;feelings of incomplete evacuation;mucus;IBS-SSS;IBS-QOL;HADS;

Countries

China

Contacts

Public ContactLi Qian

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

liqiantcm2012@163.com+86 13929504679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026